Dofetilide, a class III antiarrhythmic, is widely used in the treatment of cardiac arrhythmias. Antiarrhythmic drugs can have a long duration of action that prolongs the QT interval. This causes bradycardia that predisposes to R-on-T phenomenon subsequently leading to torsades de pointes (TdP). This necessitates constant monitoring to prevent or treat ventricular arrhythmias or bradycardia associated with cardiac medications. Although extremely rare, dofetilide overdose has been described in the literature. However, no evidence found in the current literature required prolonged intervention after the initial acute stabilization, leading to scarcity of data for treatment of ongoing dofetilide overdose. We present the case of an intentional dofetilide overdose in a 61-year-old Caucasian woman with a history of congestive heart failure, atrial fibrillation, stage IIIb chronic kidney disease, diabetes mellitus type II, hypothyroidism, morbid obesity, and hypertension that required extensive interventions for refractory TdP that lasted 4 days. Therapeutic as well as excess dosage of dofetilide can lead to TdP, which is usually controlled by decreasing the dose or terminating drug administration. If the arrhythmia is not resolved, guidelines recommend management with activated charcoal if ingestion is within 15 minutes, followed by administration of 2 g IV (intravenous) magnesium and addressing the electrolyte imbalance. However, if the arrhythmia is persistent due to ongoing dofetilide toxicity, isoproterenol is given as a bridge to overdrive pacing and dopamine is used as an alternative to isoproterenol.

1. Jaiswal, A, Goldbarg, S. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies. Indian Heart J. 2014;66(6):640-648. doi:10.1016/j.ihj.2013.12.021.
Google Scholar | Crossref | Medline2. McClellan, KJ, Markham, A. Dofetilide: a review of its use in atrial fibrillation and atrial flutter. Drugs. 1999;58(6):1043-1059. doi:10.2165/00003495-199958060-00007
Google Scholar | Crossref | Medline | ISI3. Ibrahim, MA, Kerndt, CC, Tivakaran, VS. Dofetilide. Treasure Island, FL: StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK459154/\. Accessed October 26, 2021.
Google Scholar4. Hieger, MA, Maskell, KF, Moss, MJ, Powell, SW, Cumpston, KL. Dofetilide in overdose: A case series from poison center data. Cardiovasc Toxicol. 2017;17(3):368-371. doi:10.1007/s12012-016-9384-9.
Google Scholar | Crossref | Medline5. Straus, SM, Kors, JA, De Bruin, ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362-367. doi:10.1016/j.jacc.2005.08.067.
Google Scholar | Crossref | Medline | ISI6. Chyka, PA, Seger, D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):721-741. doi:10.3109/15563659709162569.
Google Scholar | Crossref | Medline7. Thomas, SH, Behr, ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81(3):420-427. doi:10.1111/bcp.12726.
Google Scholar | Crossref | Medline8. Khan, IA. Long QT syndrome: diagnosis and management. Am Heart J. 2002;143(1):7-14. doi:101067;/mhj2002120295.
Google Scholar | Crossref | Medline9. Køber, L, Bloch Thomsen, PE, Møller, M, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet. 2000;356(9247):2052-2058. doi:10.1016/s0140-6736(00)03402-4.
Google Scholar | Crossref | Medline10. Brumberg, G, Gera, N, Pray, C, et al. Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide. Am J Cardiol. 2013;112(4): 505-508.
Google Scholar | Crossref | Medline11. Iyer, PS, Neufeld, RJ, Giambra, T, et al. Dofetilide overdose—a case of unintentional ingestion due to misinterpretation of the dose. J Pharmacy Tech. 2012;28(6):258–263. doi:10.1177/875512251202800606.
Google Scholar | SAGE Journals12. Campbell, KB, Mando, JD, Gray, AL, Robinson, E. Management of dofetilide overdose in a patient with known cocaine abuse. Pharmacotherapy. 2007;27(3):459-463. doi:10.1592/phco.27.3.459.
Google Scholar | Crossref | Medline13. Choi, BR, Burton, F, Salama, G. Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome. J Physiol. 2002;543(Pt. 2):615-631. doi:10.1113/jphysiol.2002.024570.
Google Scholar | Crossref | Medline14. Fazekas, T, Scherlag, BJ, Vos, M, Wellens, HJ, Lazzara, R. Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin Cardiol. 1993;16(11):768-774. doi:10.1002/clc.4960161105.
Google Scholar | Crossref | Medline15. Qiu, XS, Chauveau, S, Anyukhovsky, EP, et al. Increased late sodium current contributes to the electrophysiological effects of chronic, but not acute, dofetilide administration. Circ Arrhythm Electrophysiol. 2016;9(4):e003655. doi:10.1161/CIRCEP.115.003655.
Google Scholar | Crossref | Medline16. Johannesen, L, Vicente, J, Mason, JW, et al. Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial. Clin Pharmacol Ther. 2016;99(2):214-223. doi:10.1002/cpt.205.
Google Scholar | Crossref | Medline17. Cohagan, B, Brandis, D. Torsade de Pointes. Treasure Island, FL: StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK459388/. Published January 2020. Accessed October 26, 2021.
Google Scholar18. Yap, YG, Camm, AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363-1372. doi:10.1136/heart.89.11.1363.
Google Scholar | Crossref | Medline | ISI19. Sonne, J, Goyal, A, Bansal, P, Lopez-Ojeda, W. Dopamine. Treasure Island, FL: StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK535451/. Published January 202. Accessed October 26, 2021.
Google Scholar